A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
Clinical trial NCT01922037 · COMPLETED
Trial details
- NCT number
- NCT01922037
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-19
- Primary completion
- 2016-03-31
- Enrollment
- 806
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.